KDR and pulmonary hypertension: Animal models are commonly established through MCT lung injury, pulmonary hypertension caused by chronic hypoxia, and vascular endothelial growth factor receptor (VEGF-R) blockade using the tyrosine kinase inhibitor SU5416 (SU5416 plus chronic hypoxia model, SuHx model).